Introduction: Cognition refers to the perceptual and intellectual aspects of mental functioning. A deficit in intellectual performances results in lack of cognition process to cognition deficit. The present study is carried out to evaluate the efficacy of Brahmi gritha and Jyotishmathi taila in cognitive deficit.
INTRODUCTION
Cognition denotes processing of specific information including thinking, memory, perception, motivation, skilled movements and language. It refers to the perceptual and intellectual aspects of mental functioning. A deficit in intellectual performances results in lack of cognition process to cognition deficit. Cognitive deficit or cognitive impairment is an inclusive term to describe any characteristic that acts as a barrier to the cognition process. 1 The term may describe deficits in global intellectual performance, such as mental retardation. It may describe specific deficits in cognitive abilities (learning disorders, dyslexia) or it may describe drug-induced cognitive/memory impairment, such as that seen with alcohol, glucocorticoids, and benzodiazepines. 2, 3 Cognitive deficits may be congenital or caused by environmental factors such as brain injuries, neurological disorders or mental illness. 4, 5 It may be part of a syndrome, and there may be a family history of similar difficulties. It is often associated with a history of delayed developmental milestones; the age at which it becomes manifest varies according to its severity. In some children, mild cognitive deficit becomes more obvious when the child starts attending school. Cognitive deficit causes a child to learn and develop more slowly than other children, may take longer to learn to speak, walk, and take care of personal needs such as dressing or eating and may face difficulty in learning at school. They will learn, but it will take them longer. There may be some things they cannot learn. Prevalence of cognitive deficit vary according to the causative factor involved like evidence of cognitive deficit was found among 47% of pediatric transverse myelitis patients.
In Ayurvedic classics, intellect is termed as Buddhi hence deficit in intellectual functioning, i.e., cognitive deficit can be termed as Budhimandyata by means of RESEARCH ARTICLE JRAS Ayurveda. Numerous causative factors are mentioned in Ayurveda for this deficit intellectual functioning (cognitive deficit) including congenital factors (Beejadosha), nonfulfillment of desires of pregnant women (resulting into vitiation of Vatadosha), atheism of parents and their bad deeds in previous life, incompatible and improper diet, emotional and behavioral factors of the mother during pregnancy (karma, asaya, kala, dosa, ahara, vihara), suppression of natural urges (Vegadharana), and gynecological disorders (Yonidosa). [6] [7] [8] have been used in the Ayurvedic system of medicine for centuries as a medhya dravya to enhance memory. Keeping in view this facts, the selection of the drugs were done.
Importance
The long term intervention of modern synthetic drugs have their adverse effects on the body and the potential toxicity of these drugs cannot be overlooked in designing the management strategies for the cases suffering from cognitive deficit/Buddhimandyata. 9, 10 Taking the above clinical significance with its prevalence there is a great need to find an effective remedy. Hence a sincere effort has been made to manage this disease with ayurvedic treatment for the betterment of the patients suffering from cognitive deficit.
In this study malin intelligence scale for indian children (MISIC) was used for calculation of IQ and the range of IQ was taken from 70-84 which falls between borderline to dull normal. 
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MATERIALS AND METHODS
Materials
Inclusion Criteria
• Children of either sex aged between 8-13 years.
• Children of IQ 70-84 (as per MISIC).
• Willing and able to participate for 14 weeks.
Exclusion Criteria
• Children suffering from major systemic illness necessitating long-term drug treatment.
• Children with evidence of malignancy.
• Children with concurrent serious hepatic dysfunction (defined as AST and/or ALT > 3 times of the upper normal limit ) or renal dysfunction (defined as serum creatinine > 1.2 mg/dL), uncontrolled pulmonary dysfunction (asthmatic and COPD patient).
• H/O hypersensitivity to any of the trial drug or their ingredients.
• Children who have completed participation in any other clinical trial during the past 6 months.
• Any other conditions which the investigator thinks may jeopardize the study.
Method of Study
This clinical study was accomplished in three phases:
• Diagnostic phase • Interventional phase and • Assessment phase
Diagnostic Phase
Total 67 patients were diagnosed based on signs and symptoms clinical presentation and MISIC and selected for the study after the following inclusion and exclusion criteria. The nature of the study was explained to all the selected patients and their parents after that their consent (informed consent) was obtained. A special clinical proforma was prepared to incorporate both Ayurvedic (Dashavidha Pareeksha) and modern parameters. A detailed history was taken, and complete physical examination and laboratory investigations were also carried out. Relevant details of history and physical examination were done as per the 'protocol' for the study provided by CCRAS, New Delhi.
Interventional Phase: The study was intervened by the treatment with Brahmi ghrita internally in the dose of 10gms twice daily with warm water/milk before food and Nasya with Jyothishmathi Taila 2-2 drops twice daily in each nostril for 12 weeks.
Duration of Trial:
The total duration of treatment for the subjects was three months. Follow-up Study: Follow-up was conducted after one month during the trial and then after the completion of the trial. Assessment Phase: The effect of treatment (results) was assessed regarding the clinical signs and symptoms and MISIC and the overall improvement was observed and recorded as before treatment (BT) and after treatment (AT).
Assessment Criteria
Criteria adopted for improvements were changes in modified child mini-mental scale examination (MMSE), Improvement in IQ in the form of Weschler's IQ Indian adaptation by Malin (MISIC). Laboratory investigations were done to assess the safety of the drug before and after the treatment. MMSE was done at base line, 28th day, 56th day, 84th day and at the end of two weeks after completion of the treatment.
IQ (in the method of MISIC) was done at baseline and at the end of 84th day.
Lab Investigations were done at the baseline and at the end of 84th day.
Statistical Analysis
The obtained data were analyzed statistically. Primary outcome and secondary outcome measures were analyzed as the mean change in the response from baseline to 84th day by using a paired t-test. A p-value of < 0.05 was considered significant. The analysis was carried out using the statistical package for the social sciences (SPSS) version 15.0. Overall Assessment of Therapy: To assess the overall effect of therapy following criteria was laid down.
Completely Cured: More than 90% relief in symptoms and signs as well as changes of > 5 components of MMSE. Markedly Improved: More than 75% and less than 90% relief in signs and symptoms as well as changes of > 4 and < 5 components of MMSE. Moderately Improved: More than 50% and less than 75% relief in signs and symptoms as well as changes of > 2 and < 4 components of MMSE. No improvement/ Unchanged: Less than 25% relief in signs and symptoms as well as changes of < 2 components of MMSE.
The total effect of therapy was assessed on the basis of the above first three criteria.
OBSERVATIONS AND RESULTS
Total 76 cases were included for the study out of which 67 completed the trial. All the subjects were able to read and write (100%), maximum were below poverty line (55.2%), Urban habitat (68.7%), maximum patients were Hindu (88.1%), Prakriti wise distribution shows that 44 subjects were of Vata-Pittaja prakriti (65.7%) and 23 were of VataKaphaja prakriti (34.3%). According to birth history normal labor was perceived in 58 (86.6%) mothers and caesarian in nine mothers (13.4%). During child birth normal cry was present in 66 children(98.5%), jaundice was absent in 65 children (97%), cyanosis and congenital anomalies were not seen in any child. The normal milestone was observed in 55 children (82.1%) and delayed mile stone was detected in 12 children (17.9%) ( Tables 1 to 9 ).
Therapeutic response of the treatment on chief complains showed that the symptom like asking the same question repeatedly was present in 14 children (20.9%) at the baseline which was reduced to 13 children (19.4%) after completion of the treatment. Decreased learning activity was present in all 67 children (100%) at base line which was reduced to be present in 42 children (62.7%) at the end of the treatment. Inability to meet the educational demands at school was present in all 67 children (100%) at baseline which was not reduced after completion of treatment. Lack of curiosity was present in all 67 subjects (100%) which was reduced to be present in eight patients (11.9%) after treatment. Language skill (communication) retardation was present in 44 children (65.7%) which were reduced to 40 children (59.7%) at the completion of the treatment. Poor attention span was observed in 64 children (95.5%) which were reduced to be present in 9 children (13.4%) after completion of the treatment. Inability to understand and follow directions was present in 60 children (89.6%) which were reduced to be present in 58 children (86.6%) at the end of the treatment. Lost in the neighborhood and does not know how to get home was present in all the children who showed no improvement at the end of the treatment. The general health and physical development were not affected in any of the patient (Tables 10 to 18 ). Therapeutic effect of the treatment on MMSE reveals that it is having significant effects on orientation, attention, and concentration, recall, language and on total score. It is having insignificant effects on Registration and sensory perception after completion of the active treatment, i.e., at the end of 84th day. Follow-up study, i.e., at the end of 14th week (after 98 days) reveals that the drugs are continuing their significant effect on orientation, recall, language and on total score, whereas it is having no significant effect on attention and concentration, registration and sensory perception (Tables 19 and 20) .
The observations done on laboratory parameters infer that the Brahmi ghrita and Jyotishmati Taila are absolutely safe to be used in cognitive deficit children as there were no significant changes in almost all laboratory parameters statistically (Tables 21 and 22 ).
DISCUSSION
Cognitive deficit is a disorder of children with major impact on their learning ability which is generally influenced by intelligence, memory and adequate social atmosphere which are responsible for the proper development of a child. Difficulties in behavioral personality or adaptive functioning tend to exacerbate learning problems. Children with learning disabilities pay less attention than normal learners and this cannot be attributed to IQ alone. To be a good learner, a child must have less fluctuation of attention, increased the power of concentration, spontaneity in word recognition and capacity to memorize things quickly and correctly. (Nathan PJ, Clarke J, et al.). The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. 13, 14 Pratimarsha nasya is the specific treatment for the disease of the head and neck primarily related to the brain as this route provides direct administration of the drug to the brain escaping the necessity of the drug to cross the blood-brain barrier.
Hence it gives significant improvement in short duration.
Jyotishmati (Celastrus paniculata) is also Medhya drug (memory booster/neuro regenerator). It stimulates a significant decrease in the brain levels of malondialdehyde, with simultaneous significant increases in levels of glutathione and catalase. The findings of research study indicate that the aqueous extract of C. paniculata possess cognitive-enhancing properties and an antioxidant effect. Brahmi ghrita and Jyotishmati taila in the management of cognitive deficit showed good responses in the symptom, lack of curiosity from 100 to 11.9%, poor attention from 95.55 to 13.9%, moderate responses in decreasing learning activity from 100 to 59.7%, mild response in the symptom of retarded language skill from 65.7 to 59.7%, symptom of asking the same questions repeatedly from 20.9 to 17.9%, symptom of inability to understand and follow the directions from 89.6 to 86.6%. No response was observed in the symptoms like meet educational demands in school and lost in the neighborhood and does not know how to get home.
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Brahmi ghrita and Jyotishmati Taila contain drugs which are having Medhya Prabhava. 16 It increases Medha and Buddhi (cognitive functions) which causes Samprapti Vighatana, i.e., breaking of pathogenesis to help in the treatment of cognitive deficit. This improve ment may be due to Samprapti Vighatana of the disease (breaking the pathogenesis)-cognitive deficit. Brahmi ghrita and Jyotishmati Taila having Kapha-Vataghna properties which imply that these drugs clear the obstructed channels of Manovahasrotas by which these drugs may be helping in reducing the symptoms of the cognitive deficit and improves MMSE scores. Vata is considered as the controller of the mind. Pacification of the Vata also plays an important role in the action of the drugs. The brain and CSF are separated from the blood by blood brainbarrier. Lipid-soluble substances pass readily through this membrane whereas non-lipid soluble substance and proteins enter the brain much more slowly. The lipophilic action of ghee and taila facilitates the transportation of its content to the brain and nervous system. For the same reason, Ghrita, Taila, and the formulations of these facilitates an easy entry of the medicine to the target brain cells and act on the brain cells to improve the cognitive functions and MMSE scores in cognitive deficit children. The therapeutic effect on MMSE shows that the drugs are having significant effect on all symptoms except, registration and sensory perception at the end of the treatment (at the end of 84th day). The followup study (at the end of 14th week/98 days) on MMSE shows a significant effect on all symptoms except < attention and concentration and registration and sensory perception.
CONCLUSION
Cognitive deficit is a known disorder in children. It can be understood and treated in relation to Medha and Buddhi in Ayurvedic terminologies. Classical formulations of Medhya drugs mentioned in Ayurvedic classics, Brahmi ghrita (internally) and Jyotishmati taila nasya in cognitive deficit children showed good responses in the symptom, lack of curiosity from 100 to 11.9%, poor attention from 95.55 to 13.9%, moderate response in decreasing learning activity from 100 to 59.7%, mild response in the symptom of retarded language skill from 65.7 to 59.7%, symptom of asking the same questions repeatedly from 20.9 to 17.9%, symptom of inability to understand and follow the directions from 89.6 to 86.6%. No response was observed in the symptoms like meet educational demands in school and lost in the neighborhood and does not know how to get home. It also improved the MMSE scores in cognitive deficit children. Further research can be initiated by taking into account the specific causative factor or a specific component of cognitive deficit to establish the core effect of these classical formulations.
